Sanegene Bio
PrivateLast Round
Series B
Dec 8, 2025
Total Funding Raised
$266.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Sanegene Bio is a biotechnology company that develops RNA interference (RNAi) therapeutics for obesity, cardiometabolic, and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sanegene Bio Comparables
Compare Sanegene Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Argo Biopharma | 90% | |
| Rona Therapeutics | 85% | |
| Vivatides Therapeutics | 84% | |
Sanegene Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 8, 2025 | ||||
| Strategic | Nov 8, 2025 | ||||
| Series A Extension | Dec 1, 2023 | ||||
| Series A | Aug 31, 2021 | ||||
| Series A | Aug 1, 2021 |
Key People
Founding team and executive leadership
Sanegene Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alwin Capital | Series A, Series A Extension |
| SymBiosis Capital Management | Series B |
| Lake Bleu Capital | Series B |
| Shanghai Healthcare Capital | Series A Extension |
| Oriza Holdings | Series A, Series B, Series A Extension |
| Hillhouse Investment | Series B, Series A |
| Tianjin TEDA Science and Technology Investment Co., Ltd. | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 3, 2026
Partnered with Genentech to advance RNAi programs.
- Dec 8, 2025
$110M round raised
Sanegene Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sanegene Bio's valuation, stock price, and market status.